Wilsons Reaffirms Their Buy Rating on Clarity Pharmaceuticals Ltd. (CU6)

TipRanks17:35 ET · Ratings

Clarity Pharmaceuticals Target Price Cut 0.9% to A$8.40/Share by Wilsons>CU6.AU

Dow JonesDec 11 16:16 ET

Spark New Zealand to Be Removed From S&P/ASX 200 Index

MT NewswiresDec 8 17:49 ET

Vanguard Australian Shares Index ETF Has Lifted 20% in a Year. Which Stocks Have Contributed Most to Its Rise?

The Motley FoolDec 1 16:20 ET

Clarity Pharmaceuticals Completes Final Patient Assessment in Phase 2 Neuroendocrine Tumor Trial; Shares Rise 7%

MT NewswiresNov 27 22:42 ET

3 ASX 300 Stocks up by More Than 300% in a Year

The Motley FoolNov 26 17:10 ET